Delivery Order SPE2DB22D1106-SPE2DB24FDYY4

Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,136.02, is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of XYLOCAINE-MPF 1% VIAL 30ML, a pharmaceutical product. The award, valued at $1,301.92, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Xylocaine-MPF 1% vial 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,173.76 and is a Firm Fixed Price Delivery Order with a completion date of May 24, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XYLOCAINE-MPF 1% VIAL 5ML, a local anesthetic medication. The contract is a Delivery Order with a Firm Fixed Price of $1,386.88 and an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award, with ID SPE2DX15D1104|SPE2DX24F3FH9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,037.22 firm fixed-price delivery order is for the pharmaceutical product XYLOCAINE-MPF 2% VIAL 5ML, with an ultimate completion date of October 27, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,207.62, is for the supply of XYLOCAINE-MPF 1% VIAL 30ML, a medical product. The contract has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds...
The U.S. Defense Logistics Agency (DLA) awarded a $1,613.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XYLOCAINE 1% VIAL 50ML medical products. This contract, which has an ultimate completion date of August 22, 2024, is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the delivery of XYLOCAINE 2% VIAL 20ML, a pharmaceutical product, with a ceiling value of $1,637.26 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.55 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,027.93, is for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDYY4
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XYLOCAINE-MPF 1% VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The firm fixed price delivery order contract has a potential value of $1,042.89 and a period of performance through February 7, 2024.

Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is not associated with any set-aside designation. The company has a significant contracting history with the DLA Troop Support Medical organization, providing a range of pharmaceutical and medical supplies in support of military treatment programs and facilities. This award is part of Amerisourcebergen's broader indefinite delivery contract with the DLA, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver pharmaceutical products and medical materials to the DLA Troop Support Medical worldwide.

Generated 5/7/24, 11:57 AM